4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since Nov. 17.

Advertisement

1. The FoundationOne CDx is an in vitro diagnostic test that uses next-generation sequencing to identify genetic mutations in 324 genes and two genomic signatures for all solid tumor types.

2. Sublocade is a once-monthly buprenorphine injection used to treat moderate to severe opioid use disorder.

3. KardiaBand, an electrocardiogram accessory for the Apple Watch, enables users to take 30-second EKG readings and displays heart rhythm findings on the watch face.

4. The Auvi-Q 0.1 milligram epinephrine auto-injector is intended to treat serious allergic reactions in infants and young children.

More articles on supply chain:

Amazon in ‘exploratory talks’ with Mylan, Novartis, other generic drugmakers
33% of hospital workers oppose texting prescription orders, survey finds
4 things to know about the atenolol shortage

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.